Table 1.
Antimicrobial agent susceptibilities of C. Gilardii
| Antimicrobial agent | Zone diameter (mm) | EUCAST P. aeruginosa |
EUCAST P. aeruginosa |
Result | EUCAST B. pseudomallei |
EUCAST B. pseudomallei |
Result |
|---|---|---|---|---|---|---|---|
| S ≥ | R < | S ≥ | R < | ||||
| AMC | 38 | - | - | 50 | 22 | I | |
| PRL | 38 | 50 | 18 | I | - | - | |
| CAZ | 16 | 50 | 17 | R | 50 | 18 | R |
| FEP | 33 | 50 | 21 | I | - | - | |
| IPM | 40 | 50 | 20 | I | 29 | 29 | S |
| CIP | 36 | 50 | 23 | I | - | - | |
| TE | 25 | - | - | 23 | 23 | S | |
| S | 0 | - | - | - | - | ||
| CN | 0 | - | - | - | - |
* R = Resistant, I = Intermediate, S = Sensitive AMC Amoxicillin-Clavulanic Acid (30 µg), PRL Piperacillin (100 µg), CAZ Ceftazidime (10 µg), FEP Cefepime (30 µg), IPM Imipenem (10 µg), CIP Ciprofloxacin (5 µg), TEΤ Tetracycline (30 µg), S Streptomycin (10 µg), CN Gentamicin (10 µg)